Cargando…

P892: ANALYSIS OF INFECTIONS AND PARAMETERS OF HUMORAL IMMUNITY IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH TALQUETAMAB (TAL) MONOTHERAPY IN MONUMENTAL-1

Detalles Bibliográficos
Autores principales:	Rasche, Leo, Schinke, Carolina, Chari, Ajai, Lipe, Brea C., Lavi, Noa, Rodríguez-Otero, Paula, Vishwamitra, Deeksha, Skerget, Sheri, Verona, Raluca, MA, Xuewen, Khedkar, Sheetal, Hilder, Brandi, Masterson, Tara, Campagna, Michela, Renaud, Thomas, Tolbert, Jaszianne, Heuck, Christoph, Smit, Damiette, van de Donk, Niels W.C.J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431181/ http://dx.doi.org/10.1097/01.HS9.0000970472.64690.4e

Ejemplares similares

S191: PIVOTAL PHASE 2 MONUMENTAL-1 RESULTS OF TALQUETAMAB (TAL), A GPRC5DXCD3 BISPECIFIC ANTIBODY (BSAB), FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
por: Touzeau, Cyrille, et al.
Publicado: (2023)

S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM-2 RESULTS
por: Bahlis, Nizar J, et al.
Publicado: (2023)

P29 PHASE 1/2 RESULTS OF TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) (MONUMENTAL-1)
por: Minnema, M.C., et al.
Publicado: (2023)

S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
por: Mateos, Maria-Victoria, et al.
Publicado: (2023)

P10: TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED PHASE 1 RESULTS FROM MONUMENTAL-1
por: van de Donk, N. W. C. J, et al.
Publicado: (2022)

P42 HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, FROM MONUMENTAL-1
por: van de Donk, N., et al.
Publicado: (2023)

B06: SUBCUTANEOUS TALQUETAMAB IN COMBINATION WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1B RESULTS
por: Mateos, M, et al.
Publicado: (2022)

Onychomadesis and palmoplantar keratoderma associated with talquetamab therapy for relapsed and refractory multiple myeloma
por: Narayan, Neha, et al.
Publicado: (2022)

Effects of teclistamab and talquetamab on soluble BCMA levels in patients with relapsed/refractory multiple myeloma
por: Girgis, Suzette, et al.
Publicado: (2022)

Talquetamab: A promising immunotherapy for multiple myeloma
por: Tariq, Amna, et al.
Publicado: (2023)

Stratification for RRMM and Risk-Adapted Therapy: Sequencing of Therapies in RRMM
por: Jeryczynski, Georg, et al.
Publicado: (2021)

P888: MATCHED-ADJUSTED INDIRECT COMPARISON OF TALQUETAMAB VS SELINEXOR-DEXAMETHASONE AND VS BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
por: Chari, Ajai, et al.
Publicado: (2023)

Le monument /
por: Weibel, Luc
Publicado: (1994)

Jenner Monument
Publicado: (1852)

Monumental Physicians
Publicado: (1852)

Jenner Monument
Publicado: (1857)

Jenner Monument
Publicado: (1852)

The Jenner Monument
Publicado: (1853)

The Monument to Adam
por: Chandler, J. B.
Publicado: (1880)

The Hahnemann Monument
por: Cook, Joseph T., et al.
Publicado: (1897)

The Hahnemann Monument
por: James, Bushrod W.
Publicado: (1899)

The Hahnemann Monument
por: McClelland, J. H.
Publicado: (1896)

De tal palo, tal astilla /
por: Pereda, José María de, 1833-1906
Publicado: (1996)

Monuments of civilization: the Andes /
por: Guidoni, Enrico, 1939-
Publicado: (1977)

P893: COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS PHYSICIAN’S CHOICE THERAPY IN TRIPLE-CLASS EXPOSED PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MATCHED COHORT ANALYSIS
por: Oriol, Albert, et al.
Publicado: (2023)

P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL
por: Bahlis, Nizar J, et al.
Publicado: (2023)

The McDowell Monument
Publicado: (1878)

Inauguration of the Jenner Monument
Publicado: (1858)

The Rush Monument Committee
Publicado: (1888)

M’Gugin Monument
por: Ford, E. R.
Publicado: (1867)

S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY
por: Offner, Fritz, et al.
Publicado: (2023)

Escultura monumental olmeca : catálogo
por: Fuente, Beatriz de la
Publicado: (1973)

P964: PATIENT (PT)-REPORTED OUTCOMES IN PTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH BELANTAMAB MAFODOTIN (BELAMAF) VS POMALIDOMIDE/LOW DOSE DEXAMETHASONE (PD) IN THE DREAMM-3 STUDY
por: Hungria, Vania, et al.
Publicado: (2023)

La obra monumental de Sebastián = : Monumental artworks, Sebastian /
por: Sebastián, 1947-
Publicado: (2005)

Bennington´s battle monument : massive and lofty /
por: Resch, Tyler
Publicado: (1993)

Stone monuments of southern México /
por: Stirling, Matthew Williams. 1896-1975
Publicado: (1943)

The Noblest Monument of the Queen's Reign
por: Rollit, Albert
Publicado: (1887)

Monument to the Late Dr Cullen
Publicado: (1866)

Monument to Dr. Horace Wells
Publicado: (1870)

The Crawford W. Long Monument
Publicado: (1908)

Cannot write session to /tmp/vufind_sessions/sess_saf7i0t6dh5l5s796ab0m8j606